Head and Neck Squamous Cell Carcinoma (HNSCC) - Recurrent/Metastatic (R/M)

Oncology
1
Pipeline Programs
1
Companies
1
Clinical Trials
0
Approved Products

Pipeline by Development Stage

Preclinical
Phase 1
Phase 1/2
Phase 2
Phase 2/3
Phase 3
On Market
0
0
0
1
0
0
0
Early DiscoveryClinical DevelopmentMarket

Drug Modality Breakdown

Monoclonal Antibody
1100%

Competitive Landscape

1 companies ranked by most advanced pipeline stage

Coherus Oncology
Coherus OncologyCA - Redwood City
1 program
1
ToripalimabPhase 2Monoclonal Antibody1 trial
Active Trials
NCT07423078Not Yet Recruiting87Est. Mar 2031

Trial Timeline

Clinical trial activity over time

2026
2027
2028
2029
2030
2031
Coherus OncologyToripalimab

Clinical Trials (1)

Total enrollment: 87 patients across 1 trials

Window of Opportunity in Preserving Laryngeal Function Trial

Start: Mar 2026Est. completion: Mar 203187 patients
Phase 2Not Yet Recruiting

Related Jobs in Oncology

Phase Legend

PreclinicalLab & animal studies
Phase 1Safety & dosing
Phase 2Efficacy testing
Phase 3Large-scale trials
On MarketApproved & available

Key Insights

1 companies competing in this space